A Phase 3 interventional study of Clindamycin 100mg and Ketoconazole 400mg and Tetracycline 100mg and Amphotericin B 50mg in Candidiasis and Bacterial Vaginosis, sponsored by Zodiac Produtos Farmaceuticos S.A.. Status unknown at 1 site in Brazil. Open to female participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2009-04-28.
Sponsored by Zodiac Produtos Farmaceuticos S.A. · Phase 3, Interventional, and Treatment
The purpose of this study is to determine the Efficacy, Tolerability \& Safety of Combination of Clindamycin 100mg and Ketoconazole 400mg in Vaginal Capsules, used for 7 consecutive days in patients with Mixed-Type Vaginosis compared to Combination of Tetracycline 100mg and Amphotericin B 50mg in Vaginal Cream.
270 studies on the registry are indexed under Candidiasis; 20 are open to participants now.
This study's planned enrollment of 160 is above the median of 99 across 191 interventional studies indexed under Candidiasis.
Browse Candidiasis studies →Zodiac Produtos Farmaceuticos S.A. is the lead sponsor of 7 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Drug: Clindamycin 100mg and Ketoconazole 400mg
Drug: Tetracycline 100mg and Amphotericin B 50mg
Drug page: Clindamycin
1 vaginal capsule once a day at night
Drug page: Tetracycline
One full applicator, once a day at night
Efficacy based on cure rate evaluated by clinical and laboratory criteria.
Time frame: 7 days
Tolerability based on adverse events reports and patient's information
Time frame: 7 days
Safety based on adverse events reports and laboratory criterion
Time frame: 7 days
This study is status unknown, as verified in Apr 2009. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Clindamycin
Zodiac Produtos Farmaceuticos S.A.